Center Laboratories, Inc. (TPEX:4123)
Taiwan · Delayed Price · Currency is TWD 38.80
+0.35 (0.91%)
Jun 5, 2026, 1:30 PM CST
Center Laboratories Market Cap
Center Laboratories has a market cap or net worth of 28.7 billion as of June 5, 2026. Its market cap has increased by 11.45% in one year.
Market Cap
28.70B
Enterprise Value
29.86B
Revenue
1.60B
Ranking
n/a
PE Ratio
3.03
Stock Price
38.80
Market Cap Chart
Since November 3, 2004, Center Laboratories's market cap has increased from 358.01M to 28.70B, an increase of 7,917.61%. That is a compound annual growth rate of 22.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 28.63B | -7.81% |
| Dec 31, 2025 | 31.06B | -1.69% |
| Dec 31, 2024 | 31.59B | 3.14% |
| Dec 29, 2023 | 30.63B | 8.88% |
| Dec 30, 2022 | 28.13B | -7.93% |
| Dec 30, 2021 | 30.56B | -3.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lotus Pharmaceutical | 52.17B |
| Bora Pharmaceuticals | 44.45B |
| TTY Biopharm Company | 18.52B |
| ScinoPharm Taiwan | 15.58B |
| Synmosa Biopharma | 15.16B |
| YungShin Global Holding | 15.00B |
| Grape King Bio | 14.89B |
| Foresee Pharmaceuticals | 12.10B |